Adeno-associated virus (AAV) vectors have emerged as a promising tool for gene therapy, holding tremendous potential to treat a wide array of genetic disorders. However, the journey from lab to commercial production has not been without obstacles. In this video, we'll explore valuable insights into challenges and triumphs of AAV manufacturing.
